MOBILE, Ala. / Jul 30, 2025 / Business Wire / TruBridge, Inc. (NASDAQ: TBRG), a healthcare solutions company, announces participation in the Centers for Medicare & Medicaid Services’ (CMS) Health Tech Ecosystem event at the White House in Washington, D.C., where Chris Fowler, TruBridge president and CEO, signed the CMS interoperability framework pledge.
This effort aligns with the TruBridge mission to empower rural and community healthcare providers and help keep care local. TruBridge reinforces its commitment to technology that promotes data sharing, FHIR, and builds on a modern data infrastructure.
“We are determined to make a difference for the communities we serve. Enhanced interoperability helps ensure patients in rural and community settings are empowered to improve their outcomes and healthcare experiences through easy access to their data,” said Fowler. “The renewed focus on interoperability reiterates our 45-year track record of delivering tailored solutions that enable providers to remain independent and focus on what matters most, their patients.”
TruBridge pledged to provide real-time access to complete and secure health information in ways that support patient-directed access, protect privacy and follow applicable standards to enable patient facing tools without friction or delay.
To learn more about TruBridge and its tech-enabled solutions that help community health systems stay financially strong and independent, visit www.trubridge.com.
About TruBridge
TruBridge proudly supports rural and community hospitals and providers in their efforts to stay strong, independent, and deeply rooted in the communities they serve. Backed by more than 45 years of healthcare experience and trusted by over 1,500 clients nationwide, we offer a mix of technology, services, and strategic expertise — including revenue cycle management, electronic health records (EHR) and analytics — all designed singularly for the realities of rural and community healthcare. With a steadfast commitment to keeping care local, TruBridge helps hospitals flourish as the economic heart of their communities, delivering high-quality, personal care close to home. For more information, visit www.trubridge.com.
Last Trade: | US$19.85 |
Daily Change: | -0.05 -0.25 |
Daily Volume: | 44,168 |
Market Cap: | US$297.950M |
October 03, 2025 September 23, 2025 August 07, 2025 May 07, 2025 |
Terns Pharmaceuticals is a clinical-stage biopharmaceutical company developing a portfolio of small-molecule product candidates to address serious diseases, including oncology and obesity. Terns’ pipeline contains three clinical stage development programs including GLP-1 receptor...
CLICK TO LEARN MORERecursion Pharmaceuticals is a clinical stage TechBio company leading the space by decoding biology to industrialize drug discovery. Enabling its mission is the Recursion OS, a platform built across diverse technologies that continuously expands one of the world’s largest....
CLICK TO LEARN MOREEnd of content
No more pages to load